Literature DB >> 12448865

Illicit i.v. drugs. A public health approach.

Mark Haden1.   

Abstract

This article explores, from a public health perspective, the harm done by Canadian drug laws, to both individuals and society. It challenges the perceived dichotomy of legalization and criminalization of intravenous drugs. The article then expands the discussion by exploring eight legal options for illicit drugs and examines how these options interact with the marginalization of users, the illicit drug black market, and levels of drug consumption. While the main focus of this article is intravenous drugs, it draws some lessons from cannabis research.

Mesh:

Substances:

Year:  2002        PMID: 12448865      PMCID: PMC6979968     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  6 in total

Review 1.  Evaluating alternative cannabis regimes.

Authors:  R MacCoun; P Reuter
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

2.  The impact of cannabis decriminalisation in Australia and the United States.

Authors:  E Single; P Christie; R Ali
Journal:  J Public Health Policy       Date:  2000       Impact factor: 2.222

3.  A public health approach to mitigating the negative consequences of illicit drug abuse. National Association for Public Health Policy.

Authors: 
Journal:  J Public Health Policy       Date:  1999       Impact factor: 2.222

4.  Reducing the harms of drug policy: an economic perspective.

Authors:  D W Rasmussen; B L Benson
Journal:  Subst Use Misuse       Date:  1999-01       Impact factor: 2.164

5.  The impact of marijuana decriminalization: an update.

Authors:  E W Single
Journal:  J Public Health Policy       Date:  1989       Impact factor: 2.222

6.  Drug prohibition in the United States: costs, consequences, and alternatives.

Authors:  E A Nadelmann
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

  6 in total
  1 in total

1.  Enemy within?: The silent epidemic of substance dependency in GCC countries.

Authors:  Abdullah Al-Harthi; Samir Al-Adawi
Journal:  J Sci Res Med Sci       Date:  2002-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.